Literature DB >> 35462649

Revision Thyroid Surgery.

Karthik Nagaraja Rao1, Satish Satpute2, Nitin M Nagarkar3, Ambesh Singh1.   

Abstract

The incidence of recurrence in well-differentiated thyroid malignancies range from 10 to 30%. It is estimated that about 31-46% of patients with differentiated thyroid cancer will have the persistent disease and 1.2-6.8% will have structural recurrences during post-operative monitoring, depending on the initial therapy and prognostic variables. It is challenging to decide on treatment versus active monitoring following repeated or persistent tumour detection. The biological factors of the tumour and the patient guide us in the overall decision-making. Revision thyroid surgery is technically challenging. The morbidity encountered during the revision surgery is related to the anatomy of the region undergoing dissection, the degree of fibrosis and scarring from prior surgery and the operating surgeon's experience. Successful comprehensive management of revision thyroid surgery needs a multi-disciplinary approach. This review article highlights the definition, indications for revision surgery, identification of recurrent disease, management of parathyroid and recurrent laryngeal nerves with neuromonitoring. © Indian Association of Surgical Oncology 2021.

Entities:  

Keywords:  Papillary thyroid carcinoma; Recurrence; Reoperation; Revision

Year:  2021        PMID: 35462649      PMCID: PMC8986899          DOI: 10.1007/s13193-021-01467-6

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  56 in total

1.  The utility of lymph node mapping sonogram and thyroglobulin surveillance in post thyroidectomy papillary thyroid cancer patients.

Authors:  Chowdhury F Miah; Jessica A Zaman; Mitchell Simon; Tomer Davidov; Stanley Z Trooskin
Journal:  Surgery       Date:  2014-11-11       Impact factor: 3.982

2.  International neuromonitoring study group guidelines 2018: Part II: Optimal recurrent laryngeal nerve management for invasive thyroid cancer-incorporation of surgical, laryngeal, and neural electrophysiologic data.

Authors:  Che-Wei Wu; Gianlorenzo Dionigi; Marcin Barczynski; Feng-Yu Chiang; Henning Dralle; Rick Schneider; Zaid Al-Quaryshi; Peter Angelos; Katrin Brauckhoff; Jennifer A Brooks; Claudio R Cernea; John Chaplin; Amy Y Chen; Louise Davies; Gill R Diercks; Quan Yang Duh; Christopher Fundakowski; Peter E Goretzki; Nathan W Hales; Dana Hartl; Dipti Kamani; Emad Kandil; Natalia Kyriazidis; Whitney Liddy; Akira Miyauchi; Lisa Orloff; Jeff C Rastatter; Joseph Scharpf; Jonathan Serpell; Jennifer J Shin; Catherine F Sinclair; Brendan C Stack; Neil S Tolley; Sam Van Slycke; Samuel K Snyder; Mark L Urken; Erivelto Volpi; Ian Witterick; Richard J Wong; Gayle Woodson; Mark Zafereo; Gregory W Randolph
Journal:  Laryngoscope       Date:  2018-10-06       Impact factor: 3.325

3.  Completion thyroidectomy: effect of timing on clinical complications and oncologic outcome in patients with differentiated thyroid cancer.

Authors:  Gabriel Glockzin; Matthias Hornung; Klaus Kienle; Katrin Thelen; Marita Boin; Andreas G Schreyer; Hamid R Lighvani; Hans J Schlitt; Ayman Agha
Journal:  World J Surg       Date:  2012-05       Impact factor: 3.352

Review 4.  Clinical review: Clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC).

Authors:  Carole A Spencer
Journal:  J Clin Endocrinol Metab       Date:  2011-09-14       Impact factor: 5.958

5.  Recombinant human thyroid stimulating hormone-assisted radioactive iodine remnant ablation in thyroid cancer patients at intermediate to high risk of recurrence.

Authors:  Jonathan Hugo; Eyal Robenshtok; Ravinder Grewal; Steve Larson; R Michael Tuttle
Journal:  Thyroid       Date:  2012-08-08       Impact factor: 6.568

6.  Inadvertent parathyroidectomy during thyroid surgery: the incidence of a complication of thyroidectomy.

Authors:  Stavros Gourgiotis; Panagiotis Moustafellos; Nikitas Dimopoulos; George Papaxoinis; Sotirios Baratsis; Evangelos Hadjiyannakis
Journal:  Langenbecks Arch Surg       Date:  2006-09-02       Impact factor: 3.445

Review 7.  Comprehensive management of recurrent thyroid cancer: An American Head and Neck Society consensus statement: AHNS consensus statement.

Authors:  Joseph Scharpf; Michael Tuttle; Richard Wong; Drew Ridge; Russell Smith; Dana Hartl; Robert Levine; Gregory Randolph
Journal:  Head Neck       Date:  2016-09-22       Impact factor: 3.147

Review 8.  Systematic review with meta-analysis of studies comparing intraoperative neuromonitoring of recurrent laryngeal nerves versus visualization alone during thyroidectomy.

Authors:  Adolfo Pisanu; Giulia Porceddu; Mauro Podda; Alessandro Cois; Alessandro Uccheddu
Journal:  J Surg Res       Date:  2013-12-25       Impact factor: 2.192

9.  [Is the timing of completion thyroidectomy for differentiated thyroid carcinoma prognostic significant?].

Authors:  S Walgenbach; Th Junginger
Journal:  Zentralbl Chir       Date:  2002-05       Impact factor: 0.942

Review 10.  Approach to follow-up of the patient with differentiated thyroid cancer and positive anti-thyroglobulin antibodies.

Authors:  Matthew D Ringel; Fadi Nabhan
Journal:  J Clin Endocrinol Metab       Date:  2013-08       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.